Grup d'Oncogènesis i Antitumorals-GOA
banner
goasantpau.bsky.social
Grup d'Oncogènesis i Antitumorals-GOA
@goasantpau.bsky.social
Oncogenesis and Antitumor Drugs Lab at IR Sant Pau | Developing Targeted Nanotherapy for Hematological Neoplasias and Solid Tumors | Group Leader Ramon Mangues | Institut Recerca Sant Pau | CIBER-BBN | Josep Carreras Leukaemia Research Institute
Check out our last work in Biomarker research reviewing the biotechnological innovations developed for cancer therapies targeting the CXCR4 receptor.

biomarkerres.biomedcentral.com/articles/10....
Targeting the chemokine receptor CXCR4 for cancer therapies - Biomarker Research
The C-X-C chemokine receptor type 4 (CXCR4) has emerged as a key molecular biomarker for cancer therapies due to its critical role in tumor progression and metastases by displaying a stem cells phenot...
biomarkerres.biomedcentral.com
May 7, 2025 at 1:08 PM
Reposted by Grup d'Oncogènesis i Antitumorals-GOA
@goasantpau.bsky.social , with support from NANBIOSIS, have developed a targeted nanotherapy that eliminates colorectal cancer via pyroptosis, activating the immune system!

🔗 more info: www.nanbiosis.es/breakthrough...
#DíaMundialCáncerColon #ColorectalCancerDay #NanbiosisExpertise #ICTSnews
March 31, 2025 at 8:52 AM
Welcome to GOA on Bluesky! 🔬🧪 Our research focuses on developing targeted nanoparticles as a cutting-edge therapeutic approach for cancer treatment. Follow us for updates on our journey to revolutionize cancer therapy! #CancerResearch #Nanomedicine #TargetedTherapy
March 31, 2025 at 10:00 AM